CompletedNot Applicable

Lymphoedema Among Persons With Head- and Neck Cancer

Sweden50 participantsStarted 2022-10-01

Plain-language summary

Lymphedema in the head and neck area is common after treatment for head and neck cancer. The aim of the research project is: • to assess the prevalence of lymphedema in patients with head and neck cancer (HNC) by measuring the amount of tissue water in the head and neck area before and after different kinds of cancer treatment, and to evaluate the quality of life before and after cancer treatment.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Biopsy or cytology confirmed HNC (all malignant types are accepted) from the oropharynx (OPC), oral cavity (OC) or neck metastases from unknown primary cancer of the head and neck (CUP). * Tumour stage T1-4, N0-3. * Planned for treatment with curative intent as recommended at the multidisciplinary tumour board. * Age \>18 years. Able to give informed consent Exclusion Criteria: * Previous treatment of HNC or radiation to the head and neck area. * Planned surgery that includes free tissue transfer or pedicled flaps in the neck (local facial pedicled flaps are accepted). * Planned neck dissection involving less than three regions of the neck. * Planned proton therapy. * Pre-treatment surgery or Botox injections in the tissue in the head and neck area. * Pregnancy

What they're measuring

Change in level of tissue water

Timeframe: Baseline and after 3 and 9 months

Trial details

NCT IDNCT05316974

SponsorLund University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-10-31

View on ClinicalTrials.gov More Cancer of Head and Neck trials